An End-to-End Platform for Next-Generation CAR-T Development and Clinical Translation
JWeave is JW Therapeutics' proprietary end-to-end CAR-T technology platform, spanning every critical stage of development and manufacturing—from gene of interest (GOI) discovery and vector design to process development, viral vector manufacturing, cell engineering, cell expansion, and quality control (QC) release.
Built on a foundation of standardization, modularity, and automation, the platform enables the efficient development and robust manufacturing of multi-target and armored CAR-T therapies. By integrating R&D efficiency, process excellence, and scalable manufacturing, Jweave™ accelerates the translation of next-generation cell therapies and strengthens JW Therapeutics' global innovation capabilities.